Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.

Smith, Robert Løvsletten; O'Connell, Kevin; Athanasiu, Lavinia; Djurovic, Srdjan; Kringen, Marianne Kristiansen; Andreassen, Ole A; Molden, Espen

Smith, Robert Løvsletten; O'Connell, Kevin; Athanasiu, Lavinia; Djurovic, Srdjan; Kringen, Marianne Kristiansen; Andreassen, Ole A; Molden, Espen.

Afiliação

Smith RL; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
O'Connell K; CoE NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Athanasiu L; CoE NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Djurovic S; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Kringen MK; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.
Andreassen OA; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
Molden E; Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway.

Transl Psychiatry ; 10(1): 366, 2020 Nov 02.

Article em En | MEDLINE | ID: mdl-33139722

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Transl Psychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google